DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Clinical trial NCT04963231 · COMPLETED
Trial details
- NCT number
- NCT04963231
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-08-04
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.